13D Filing: Novo A/s and Htg Molecular Diagnostics Inc (NASDAQ:HTGM)

person has previously filed a statement on Schedule 13G to report the acquisition which is subject of this Schedule 13D, and is filing this statement because of Rule 13d-1(e), ...

Keep Reading →